N-[(S)-1-{3-[4-(3-Amino-propylamino)-butylamino]-propylcarbamoyl}-2-(4-hydroxy-phenyl)-ethyl]-butyramide

ID: ALA16117

Chembl Id: CHEMBL16117

Cas Number: 115976-93-7

PubChem CID: 159548

Max Phase: Preclinical

Molecular Formula: C23H41N5O3

Molecular Weight: 435.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Philanthotoxin-343 | Philanthotoxin 343|Philanthotoxin-343|115976-93-7|Phtx 343|CHEMBL16117|CHEBI:34920|PHILANTHOTOXIN 343 TRIS-TRIFLUOROACETATE|N-[(2S)-1-[3-[4-(3-aminopropylamino)butylamino]propylamino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]butanamide|PhTX-343|AC1Q5PFY|VS3BZ5F9WP|(S)-Philanthotoxin 343|PhTX-343 TFA|SCHEMBL8391460|DTXSID20921884|N-[1-{3-[4-(3-Amino-propylamino)-butylamino]-propylcarbamoyl}-2-(4-hydroxy-phenyl)-ethyl]-butyramide|BDBM50094298|AKOS040753555|Q27116321|(alphaS)-N-[3-Show More

Canonical SMILES:  CCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCCNCCCCNCCCN

Standard InChI:  InChI=1S/C23H41N5O3/c1-2-7-22(30)28-21(18-19-8-10-20(29)11-9-19)23(31)27-17-6-16-26-14-4-3-13-25-15-5-12-24/h8-11,21,25-26,29H,2-7,12-18,24H2,1H3,(H,27,31)(H,28,30)/t21-/m0/s1

Standard InChI Key:  DTWANULJDRVTFI-NRFANRHFSA-N

Associated Targets(Human)

CHRNA1 Tclin Acetylcholine receptor; alpha1/beta1/delta/gamma (501 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRND Tclin Acetylcholine receptor protein delta chain (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRM1 Tchem Metabotropic glutamate receptor 1 (2309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Glutamate NMDA receptor; GRIN1/GRIN2A (719 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNB4 Tclin Neuronal acetylcholine receptor; alpha3/beta4 (2283 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNB2 Tclin Neuronal acetylcholine receptor; alpha4/beta2 (3972 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gria2 Glutamate receptor ionotropic, AMPA (2103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria1 Glutamate receptor ionotropic, AMPA 1 (398 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria2 Glutamate receptor AMPA 1/2 (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 435.61Molecular Weight (Monoisotopic): 435.3209AlogP: 1.03#Rotatable Bonds: 18
Polar Surface Area: 128.51Molecular Species: BASEHBA: 6HBD: 6
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.41CX Basic pKa: 10.76CX LogP: -1.01CX LogD: -5.97
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.19Np Likeness Score: -0.04

References

1. Strømgaard K, Mellor IR, Andersen K, Neagoe I, Pluteanu F, Usherwood PN, Krogsgaard-Larsen P, Jaroszewski JW..  (2002)  Solid-phase synthesis and pharmacological evaluation of analogues of PhTX-12-A potent and selective nicotinic acetylcholine receptor antagonist.,  12  (8): [PMID:11934578] [10.1016/s0960-894x(02)00120-8]
2. Strømgaard K, Brier TJ, Andersen K, Mellor IR, Saghyan A, Tikhonov D, Usherwood PN, Krogsgaard-Larsen P, Jaroszewski JW..  (2000)  Solid-phase synthesis and biological evaluation of a combinatorial library of philanthotoxin analogues.,  43  (23): [PMID:11087577] [10.1021/jm000220n]
3. Jørgensen MR, Olsen CA, Mellor IR, Usherwood PN, Witt M, Franzyk H, Jaroszewski JW..  (2005)  The effects of conformational constraints and steric bulk in the amino acid moiety of philanthotoxins on AMPAR antagonism.,  48  (1): [PMID:15634001] [10.1021/jm049906w]
4. Fleming JJ, England PM..  (2010)  Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.,  18  (4): [PMID:20096591] [10.1016/j.bmc.2009.12.072]
5. Frølund S, Bella A, Kristensen AS, Ziegler HL, Witt M, Olsen CA, Strømgaard K, Franzyk H, Jaroszewski JW..  (2010)  Assessment of structurally diverse philanthotoxin analogues for inhibitory activity on ionotropic glutamate receptor subtypes: discovery of nanomolar, nonselective, and use-dependent antagonists.,  53  (20): [PMID:20873775] [10.1021/jm100886h]
6. Eldefrawi AT, Eldefrawi ME, Konno K, Mansour NA, Nakanishi K, Oltz E, Usherwood PN..  (1988)  Structure and synthesis of a potent glutamate receptor antagonist in wasp venom.,  85  (13): [PMID:2838850] [10.1073/pnas.85.13.4910]
7. Kachel HS, Franzyk H, Mellor IR..  (2019)  Philanthotoxin Analogues That Selectively Inhibit Ganglionic Nicotinic Acetylcholine Receptors with Exceptional Potency.,  62  (13): [PMID:31244109] [10.1021/acs.jmedchem.9b00519]

Source